Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Riluzole in Patients With Spinocerebellar Ataxia Type 7: a Randomized , Double-blind, Placebo-controlled Pilot Trial With a Lead in Phase

NCT03660917 is registered in ClinicalTrials.gov with S. Andrea Hospital as lead sponsor.

NCT NCT03660917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03660917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Riluzole in Patients With Spinocerebellar Ataxia Type 7: a Randomized , Double-blind, Placebo-controlled Pilot Trial With a Lead in Phase
Lead sponsor
S. Andrea Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
June 1, 2021
Completion date
September 1, 2026
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sca7